1
|
Sebaiy MM, El-Adl SM, Baraka MM, Hassan AA, El-Sayed HM. Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma. BMC Chem 2022; 16:70. [PMID: 36127740 PMCID: PMC9487044 DOI: 10.1186/s13065-022-00864-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Accepted: 08/29/2022] [Indexed: 11/21/2022] Open
Abstract
A new rapid, simple, and sensitive RP-HPLC method was carried out through applying Quality by Design approach for determination of xipamide and valsartan in Human plasma. Fractional factorial design was used for screening of four independent factors: pH, flow rate, detection wavelength, and % of MeOH. Analysis of variance (ANOVA) confirmed that flow rate and % of MeOH were only significant. Chromatographic conditions optimization was carried out through using central composite design. Method analysis was performed using BDS Hypersil C8 column (250 × 4.6 mm, 5 μm) and an isocratic mobile phase of MeOH and 0.05 M KH2PO4 buffer pH 3 (64.5:35.5, v/v) at 1.2 mL/min flow rate with UV detection at 240 nm and 10 μL injection volume. According to FDA guidelines, the method was then validated for the determination of the two drugs clinically in human plasma in respect of future pharmacokinetic and bioequivalence simulation studies. The standard curve was linear in the concentration range of 5-100 µg/mL for both drugs, with a determination coefficient (R2) of 0.999. Also, the average recoveries lied within the range from 99.89 to 100.03%. The proposed method showed good predictability and robustness.
Collapse
Affiliation(s)
- Mahmoud M Sebaiy
- Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
| | - Sobhy M El-Adl
- Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
| | - Mohamed M Baraka
- Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
| | - Amira A Hassan
- Medicinal Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
| | - Heba M El-Sayed
- Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
| |
Collapse
|
2
|
V G, Basuri PP, Sahini K, C N N. Retention behaviour of analytes in reversed phase high performance liquid chromatography - A review. Biomed Chromatogr 2022:e5482. [PMID: 35962484 DOI: 10.1002/bmc.5482] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2022] [Revised: 08/08/2022] [Accepted: 08/10/2022] [Indexed: 11/10/2022]
Abstract
The understanding of principles that drive the separation in reversed phase chromatography plays an important role in the prediction of elution of solutes in RP-HPLC. The separation in RP-HPLC is based on the principle of adsorption and partition. In addition, the log P value, pKa value of the drug, chromatographic parameters like mobile phase pH, buffer concentration, organic modifier and mobile phase additives also influence the retention and selectivity of the analyte. It is found that hydrophobic, electrostatic, hydrogen bonding and other specific interactions between the stationary phase and the solutes along with the hydrophobicity of an analyte molecule (log P) modify the retention behaviour of the analytes. This article gives special attention to the influence of ionization and ion interaction on the separation of analytes. The drug molecules with different log P value containing protonated and deprotonated acids, bases and zwitterions are selected as examples and this article addresses various issues related to method development, relationships between analyte retention and mobile phase pH and pKa value of the analyte. The advances in this regard, with highlights on topics such as mechanisms of retention and various factors that influence the retention behaviour of analytes is also updated with suitable examples.
Collapse
Affiliation(s)
- Ganesh V
- Department of Pharmaceutical analysis, C. L. Baid Metha College of pharmacy, Chennai, India
| | - P Poorna Basuri
- Department of Pharmaceutical analysis, C. L. Baid Metha College of pharmacy, Chennai, India
| | - K Sahini
- Department of Pharmaceutical analysis, C. L. Baid Metha College of pharmacy, Chennai, India
| | - Nalini C N
- Department of Pharmaceutical analysis, C. L. Baid Metha College of pharmacy, Chennai, India
| |
Collapse
|
3
|
Development and Validation of Bioanalytical Method for Determination of Nebivolol and Valsartan in Human Plasma by Using RP-HPLC. EUROPEAN PHARMACEUTICAL JOURNAL 2022. [DOI: 10.2478/afpuc-2021-0019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Abstract
Aim
Nebivolol and valsartan are used in the treatment of hypertension. So, this study was conducted for the purpose of determining bioavailability/bioequivalence of nebivolol and valsartan in human plasma.
Materials and Methods
The chromatographic separation was performed on Symmetry C18 (150 × 4.6 mm, 5 μm) column using 0.01 N potassium dihydrogen phosphate (pH 3.0):acetonitrile (60:40) as the mobile phase at a flow rate of 1.0 mL/min and a detector wavelength of 280 nm. The retention times of nebivolol and valsartan in plasma were found to be 3.1 and 4.3 min, respectively.
Results
The method was validated statistically and by recovery studies. The linearity concentration was acceptable in the range of 0.5–10 ng/mL for nebivolol and 400–8000 ng/mL for valsartan. The lower limits of quantification were 0.5 ng/mL for nebivolol and 400 ng/mL for valsartan, which reached the levels of both drugs possibly found in human plasma. Per cent recoveries were obtained as 97.78% and 98.11% for nebivolol and valsartan, respectively.
Conclusion
The proposed method is simple, rapid, accurate, precise and gives us knowledge about the pharmacokinetics and therapeutic drug monitoring in clinical laboratories.
Collapse
|
4
|
Kamal AH, Marie AA, Hammad SF. Validated spectrophotometric methods for simultaneous determination of nebivolol hydrochloride and valsartan in their tablet. Microchem J 2020. [DOI: 10.1016/j.microc.2020.104741] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
5
|
Meselhy EM, Aboul Kheir AA, El Henawee MM, Elmasry MS. Simultaneous determination of Nebivolol hydrochloride and Valsartan in their binary mixture using different validated spectrophotometric methods. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2020; 230:118083. [PMID: 32004869 DOI: 10.1016/j.saa.2020.118083] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Revised: 01/17/2020] [Accepted: 01/19/2020] [Indexed: 06/10/2023]
Abstract
Five simple, sensitive, accurate and precise spectrophotometric methods were developed for the simultaneous determination of Nebivolol hydrochloride (NEB) and Valsartan (VAL) in their binary mixtures and in pharmaceutical dosage form. The methods included Ratio Difference, First Derivative ratio, Mean Centering of ratio spectra, Bivariate and H-Point Standard additions method. The calibration curves were linear over the concentration range of 10-70 μg/ml and 20-60 μg/ml for NEB and VAL, respectively for Ratio Difference and First Derivative ratio method and over the concentration range of 10-70 μg/ml and 10-60 μg/ml for NEB and VAL, respectively for Mean Centering of ratio spectra, Bivariate and H-Point Standard additions method. These methods were examined by analyzing synthetic mixtures of the studied drugs and they were utilized to determine the studied drugs in their commercial pharmaceutical preparation. All methods were validated as per ICH guidelines and accuracy, robustness, repeatability and precision were found to be within the acceptable limits. The results of the proposed methods were compared to the results of reported methods with no significant difference between them.
Collapse
Affiliation(s)
- Esraa M Meselhy
- Analytical Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo 11829, Egypt
| | - Afaf A Aboul Kheir
- Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
| | - Magda M El Henawee
- Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
| | - Manal S Elmasry
- Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
| |
Collapse
|
6
|
Smajić M, Vujić Z. Application of central composite design and structural analysis to the optimization of HPLC method for simultaneous analysis of hydrochlorothiazide, amlodipine besylate and valsartan. MAIN GROUP CHEMISTRY 2018. [DOI: 10.3233/mgc-180259] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Affiliation(s)
- Miralem Smajić
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Tuzla, Univerzitetska, Tuzla, Bosnia and Herzegovina
| | - Zorica Vujić
- Faculty of Pharmacy, Institute for Pharmaceutical Chemistry, University of Belgrade, Vojvode Stepe, Belgrade, Serbia
| |
Collapse
|
7
|
Ravi P, Vats R, Joseph S, Gadekar N. Development and validation of simple, rapid and sensitive LC-PDA ultraviolet method for quantification of Nebivolol in rat plasma and its application to pharmacokinetic studies. ACTA CHROMATOGR 2015. [DOI: 10.1556/achrom.27.2015.2.6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
8
|
Abstract
Valsartan is an antihypertensive drug which selectively inhibits angiotensin receptor type II. Generally, valsartan is available as film-coated tablets. This review summarizes thermal analysis, spectroscopy characteristics (UV, IR, MS, and NMR), polymorphism forms, impurities, and related compounds of valsartan. The methods of analysis of valsartan in pharmaceutical dosage forms and in biological fluids using spectrophotometer, CE, TLC, and HPLC methods are discussed in details. Both official and nonofficial methods are described. It is recommended to use LC-MS method for analyzing valsartan in complex matrices such as biological fluids and herbal preparations; in this case, MRM is preferred than SIM method.
Collapse
Affiliation(s)
- Febry Ardiana
- Research & Development, Bernofarm Pharmaceutical Company, Buduran-Sidoarjo, Indonesia
| | - Gunawan Indrayanto
- Faculty of Pharmacy, Airlangga University, Dharmawangsa Dalam, Surabaya, Indonesia.
| |
Collapse
|
9
|
Muszalska I, Sobczak A, Dołhań A, Jelińska A. Analysis of Sartans: a review. J Pharm Sci 2013; 103:2-28. [PMID: 24227012 DOI: 10.1002/jps.23760] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2013] [Revised: 10/03/2013] [Accepted: 10/03/2013] [Indexed: 11/05/2022]
Abstract
The risk of cardiovascular diseases is closely related to hypertension, high cholesterol levels, and diabetes. When these risk factors appear together they are referred to as a metabolic syndrome. In the treatment of cardiovascular diseases, a combination of antihypertensive, hypolipemiant, and antidiabetic drugs is often applied. Diuretics (chlortalidone, hydrochlorothiazide, etc.) and angiotensin II receptors antagonist (sartans) are used to control hypertension, whereas statins (fluvastatin, simvastatin, etc.) are used to reduce cholesterol levels. This review is concerned with methods for the analysis of sartans in various matrices, such as pharmaceutical formulations, environmental and biological samples, and discusses the current status of stability studies of sartans . It also presents analytical methods for the simultaneous determination of sartans, diuretics, and statins.
Collapse
Affiliation(s)
- Izabela Muszalska
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Grunwaldzka 6, Poznań, 60-780, Poland
| | | | | | | |
Collapse
|
10
|
Visweswara Rao K, Padmaja Reddy K, Haldar P. A Validated Chiral LC Method for Enantiomeric Separation of Nebivolol Stereoisomers in Bulk Drugs and Dosage Forms on Amylose-Based Stationary Phase. J Chromatogr Sci 2013; 52:1051-8. [DOI: 10.1093/chromsci/bmt158] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|